Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - Re: 148-reexam: Non-Final Action Mailed on 12-21-2007* Milestone

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

148-reexam: Non-Final Action Mailed on 12-21-2007

jay68

Dec 21, 2007 08:47AM

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007

Bartender

Dec 21, 2007 08:54AM

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007

milestone

Dec 21, 2007 09:30AM

optymystic

Rank: President [?]

Points: 18922 [?]

Votes: 159 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007* Milestone

in response to

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007

milestone

posted on Dec 21, 2007 09:36AM

Thanks for that heads up. I take it you are saying then that if the initial office action was a rejection, it would say so. Correct. Thanks again for all you do to keep us well informed. Opty

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007

Wings05

Dec 21, 2007 09:44AM

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007 meaning

borredo

Dec 21, 2007 09:47AM

Re: 148-reexam: Non-Final Action Mailed on 12-21-2007 Borredo

optymystic

Dec 21, 2007 09:56AM

Re: 148-reexam: borredo

milestone

Dec 21, 2007 09:58AM